[go: up one dir, main page]

AR030554A1 - SIMILAR MOLECULES TO IL-17 RECEPTORS AND USES OF THE SAME - Google Patents

SIMILAR MOLECULES TO IL-17 RECEPTORS AND USES OF THE SAME

Info

Publication number
AR030554A1
AR030554A1 ARP010101203A ARP010101203A AR030554A1 AR 030554 A1 AR030554 A1 AR 030554A1 AR P010101203 A ARP010101203 A AR P010101203A AR P010101203 A ARP010101203 A AR P010101203A AR 030554 A1 AR030554 A1 AR 030554A1
Authority
AR
Argentina
Prior art keywords
receptors
same
similar molecules
polypeptides
methods
Prior art date
Application number
ARP010101203A
Other languages
Spanish (es)
Inventor
Shuqian Jing
Eugene Medlock
Richard Yeh
Scott M Silbiger
Gary S Elliot
Hung Q Nguyen
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AR030554A1 publication Critical patent/AR030554A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Nuevos polipéptidos similares a receptores IL-17 y moléculas de ácido nucleico que los codifican. El invento también se refiere a vectores, células huésped, agonistas y antagonistas (incluyendo agentes enlazantes selectivos) y métodos para producir polipéptidos semejantes a receptores IL-17. También se proveen métodos para el tratamiento, diagnostico, mejora o prevencion de enfermedades con polipéptidos similares a receptores IL-17.New polypeptides similar to IL-17 receptors and nucleic acid molecules that encode them. The invention also relates to vectors, host cells, agonists and antagonists (including selective binding agents) and methods for producing IL-17 receptor-like polypeptides. Methods for the treatment, diagnosis, improvement or prevention of diseases with polypeptides similar to IL-17 receptors are also provided.

ARP010101203A 2000-03-16 2001-03-15 SIMILAR MOLECULES TO IL-17 RECEPTORS AND USES OF THE SAME AR030554A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18992300P 2000-03-16 2000-03-16
US20420800P 2000-05-12 2000-05-12
US72323200A 2000-11-27 2000-11-27
US26615901P 2001-02-02 2001-02-02

Publications (1)

Publication Number Publication Date
AR030554A1 true AR030554A1 (en) 2003-08-27

Family

ID=27497823

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101203A AR030554A1 (en) 2000-03-16 2001-03-15 SIMILAR MOLECULES TO IL-17 RECEPTORS AND USES OF THE SAME

Country Status (8)

Country Link
EP (1) EP1265924A2 (en)
JP (1) JP2003527117A (en)
AR (1) AR030554A1 (en)
AU (2) AU2001259029B2 (en)
CA (1) CA2401273A1 (en)
MX (1) MXPA02009024A (en)
TW (1) TWI322154B (en)
WO (1) WO2001068705A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7771719B1 (en) * 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
AU740405B2 (en) 1998-05-15 2001-11-01 Genentech Inc. IL-17 homologous polypeptides and therapeutic uses thereof
EP1897943B1 (en) * 1999-12-23 2011-12-14 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US20040043397A1 (en) 2000-01-11 2004-03-04 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2007202616B2 (en) * 2000-06-22 2011-08-18 Amgen Inc. IL-17 Like Molecules and Uses Thereof
CA2425506A1 (en) 2000-10-18 2002-08-01 Immunex Corporation Methods for treating rheumatoid arthritis using il-17 antagonists
AU2003263751A1 (en) * 2002-08-05 2004-02-23 Eli Lilly And Company Novel proteins and their uses
WO2004024076A2 (en) * 2002-09-11 2004-03-25 Genentech, Inc. Novel compositions and methods for the treatment of immune related diseases
CA2638864A1 (en) * 2006-02-10 2007-10-18 Zymogenetics, Inc. Truncated il-17ra soluble receptor and methods of using in inflammation
US7767206B2 (en) 2006-10-02 2010-08-03 Amgen Inc. Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
WO2008067057A2 (en) * 2006-10-13 2008-06-05 The Regents Of The University Of California Cancer treatment
WO2009069355A1 (en) * 2007-11-28 2009-06-04 Riken Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell
US20090317400A1 (en) 2008-05-05 2009-12-24 Krzysztof Masternak Anti-IL 17A/IL-17F Cross-Reactive Antibodies and Methods of Use Thereof
GB0905972D0 (en) 2009-04-06 2009-05-20 Medical Res Council Antibodies against IL-17BR
RU2605318C2 (en) 2009-05-05 2016-12-20 Новиммун С.А. Anti-il-17f antibodies and methods for use thereof
PL3295957T3 (en) 2010-01-15 2020-03-31 Kirin-Amgen, Inc. Anti il-17ra antibody formulation and therapeutic regimens for treating psoriasis
PH12012501884B1 (en) * 2010-03-30 2018-04-13 Janssen Biotech Inc Humanized il-25 antibodies
US9284283B2 (en) 2012-02-02 2016-03-15 Ensemble Therapeutics Corporation Macrocyclic compounds for modulating IL-17

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83878A (en) 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
US4892538A (en) 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
US5106627A (en) 1987-11-17 1992-04-21 Brown University Research Foundation Neurological therapy devices
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5319071A (en) 1987-11-25 1994-06-07 Immunex Corporation Soluble interleukin-1 receptors
WO1989004838A1 (en) 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
EP0510691B1 (en) 1991-04-26 2004-11-03 Osaka Bioscience Institute DNA coding for human cell surface antigen
US5489743A (en) 1993-01-19 1996-02-06 Amgen Inc. Transgenic animal models for thrombocytopenia
US6664107B1 (en) 1993-05-26 2003-12-16 Ontario Cancer Institute, University Health Network CD45 disrupted nucleic acid
AU6760794A (en) 1993-05-26 1994-12-20 Ontario Cancer Institute, The Transgenic mammals lacking expression of particular cd45 isoforms
WO1995001997A1 (en) 1993-07-09 1995-01-19 Smithkline Beecham Corporation RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
AU705281B2 (en) 1994-12-23 1999-05-20 Uab Research Foundation Secreted human fas antigen
WO1996041865A1 (en) 1995-06-07 1996-12-27 Ariad Gene Therapeutics, Inc. Rapamcycin-based regulation of biological events
WO1997031898A1 (en) 1996-02-28 1997-09-04 Ariad Gene Therapeutics, Inc. Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
US6482923B1 (en) * 1997-09-17 2002-11-19 Human Genome Sciences, Inc. Interleukin 17-like receptor protein
US6635443B1 (en) * 1997-09-17 2003-10-21 Human Genome Sciences, Inc. Polynucleotides encoding a novel interleukin receptor termed interleukin-17 receptor-like protein
AU2315099A (en) * 1998-01-09 1999-07-26 Immunex Corporation Il-17rh dna and polypeptides
AU3207000A (en) * 1999-01-11 2000-08-01 Schering Corporation Interleukin-17 related mammalian cytokine (il-171). polynucleotides encoding them. uses
JP2002540791A (en) * 1999-04-05 2002-12-03 インサイト・ファーマスーティカルズ・インコーポレイテッド Immune system molecules
US7094886B2 (en) * 2000-02-04 2006-08-22 Board Of Trustees Of The University Of Arkansas Evi27 gene sequences and protein encoded thereby
TWI238191B (en) * 2000-02-08 2005-08-21 Amgen Inc IL-17 like molecules and uses thereof
US9100155B2 (en) 2010-05-03 2015-08-04 Qualcomm Incorporated Method and apparatus for control and data multiplexing in wireless communication
JP6160461B2 (en) 2013-11-29 2017-07-12 富士通株式会社 Likelihood weighting circuit

Also Published As

Publication number Publication date
AU2001259029B2 (en) 2006-01-05
CA2401273A1 (en) 2001-09-20
JP2003527117A (en) 2003-09-16
WO2001068705A2 (en) 2001-09-20
WO2001068705A3 (en) 2002-07-18
AU5902901A (en) 2001-09-24
EP1265924A2 (en) 2002-12-18
TWI322154B (en) 2010-03-21
MXPA02009024A (en) 2003-02-12

Similar Documents

Publication Publication Date Title
AR030236A1 (en) MOLECULES SIMILAR TO IL-17 AND USES OF THE SAME
AR030554A1 (en) SIMILAR MOLECULES TO IL-17 RECEPTORS AND USES OF THE SAME
EP1363632A4 (en) RECEPTOR SELECTIVE CANNABIMIMETIC AMINOALKYLINDOLS
UY28348A1 (en) NEW COMPOUNDS
NO20010062L (en) Biphenylsulfonamides as dual angiotensin-endothelin receptor antagonists
ECSP088508A (en) NEUROPILINE ANTAGONISTS
NO20030374L (en) Cyclopentanoindoles, preparations containing such compounds and treatment methods
EA200501430A1 (en) Cannabinoid receptor ligands and their use
BRPI0113286B8 (en) substituted pyrazoles and pharmaceutical composition comprising the same.
DK0817770T3 (en) Nonpeptides as tachykinin antagonists
EA200500520A1 (en) PURINE COMPOUNDS AND THEIR APPLICATION AS CANCELINOID RECEPTOR LIGANDS AS LIGANDS
NO20010446L (en) Substituted anilide compounds and methods
BR0208957A (en) 3,4-disubstituted cyclobutene-1,2-diones as cxc chemokine receptor ligands
DE69942459D1 (en) ISOLATED NUCLEIC ACID MOLECULES COPYING T CELLS INDUCIBLE FACTORS (TIF), ENCODING PROTEINS AND THEIR USE
DE60106954D1 (en) Resorcinol DERIVATIVES
ECSP066559A (en)
HN2002000365A (en) LACTAMAS AS TAQUIQUININE ANTAGONISTS
WO2001068859A3 (en) Il-17 receptor like molecules and uses thereof
AR028579A1 (en) METHOD FOR THE TREATMENT OF VAGINAL DROUGHT, WITH NICOTINIC ACETILCOLINE RECEPTOR AGONISTS
ECSP003707A (en) DIAZEPANES
TR199700956T1 (en) Indazole carboxamides.
DK1196442T3 (en) VGF polypeptides and methods for the treatment of VGF-related disorders
ATE247130T1 (en) UROKINASE RECEPTOR INHIBITORS
ES2100051T3 (en) SYNTHESIS OF DIMER BLOCKS AND THEIR USE IN THE ASSEMBLY OF OLIGONUCLEOTIDES.
UY26265A1 (en) CALCIOLYTIC COMPOUNDS

Legal Events

Date Code Title Description
FB Suspension of granting procedure